Cargando…
MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
Autores principales: | Fan, Z, Cui, H, Yu, H, Ji, Q, Kang, L, Han, B, Wang, J, Dong, Q, Li, Y, Yan, Z, Yan, X, Zhang, X, Lin, Z, Hu, Y, Jiao, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945745/ https://www.ncbi.nlm.nih.gov/pubmed/27159676 http://dx.doi.org/10.1038/oncsis.2016.21 |
Ejemplares similares
-
MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016) -
Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma
por: Yu, X, et al.
Publicado: (2013) -
MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
por: Wang, H, et al.
Publicado: (2014) -
miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
por: Shen, Y, et al.
Publicado: (2013) -
SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway
por: Yuan, L-J, et al.
Publicado: (2015)